(Q40827410)

24 September 2017

title

Bromocriptine suppression of plasma growth hormone in acromegaly (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336245

26 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

26 March 2023

3

Espiner EA

1 reference

24 September 2017

2

Donald RA

1 reference

24 September 2017

P. J. Dunn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336245

26 March 2023

R. A. Donald

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336245

26 March 2023

E. A. Espiner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A336245

26 March 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=336245

26 March 2023

publication date

1 October 1977

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2265.1977.tb01326.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.1977.tb01326.x/fullpdf

26 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

26 March 2023

published in

Clinical Endocrinology

1 reference

24 September 2017

volume

7

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

273-281

1 reference

Bromocriptine therapy in acromegaly

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.1977.TB01326.X

The New Zealand Medical Journal

21 January 2018

2

74

306

BELL J.P.

1971

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Stable Reduction of Plasma Growth Hormone (hGH) Levels During Chronic Administration of 2-Br-α-ergocryptine (CB-154) in Acromegalic Patients

26 March 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

The New Zealand Medical Journal

26 March 2023

4

81

COWLES R.J.

1975

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

The plasma gonadotropin response to gonadotropin-releasing hormone in patients with primary hypogonadism.

26 March 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Modifications of a specific assay for hydroxyproline in urine

26 March 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration

26 March 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

A Homologous Radioimmunoassay for Human Prolactin1

26 March 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Treatment of acromegaly with bromocryptine

26 March 2023

11

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Bromocriptine treatment of acromegaly

26 March 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Charcoal-dextran radioimmunoassay of human growth hormone

26 March 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

Transactions of the American Neurological Association

26 March 2023

14

93

56

YAHR M.D.

1968

1 reference

https://api.crossref.org/works/10.1111/J.1365-2265.1977.TB01326.X

26 March 2023

Identifiers

1 reference

24 September 2017

1 reference